Independent sourcing consultancy

Clear about the work.
Clear about the limits.

US Med Access organizes specialty medication reference information and supports case-specific introductions to licensed European dispensing providers. We do not dispense, prescribe, stock, sell, or distribute medications.

Business modelConsultancy
Dispensing statusNot a pharmacy
Decision modelCase-specific
Catalog scope179 profiles

Editorial accountability

Who publishes.
How we review.

Public content is maintained by the US Med Access sourcing research team. It is informational, source-led, and separate from medical, legal, or pharmacy advice.

Published by
US Med Access, an independent specialty medication sourcing consultancy and facilitation service.
Review standard
Medication identity, package fields, cited public sources, comparison labels, and service limitations are checked before publication.
Update policy
Material source, package, methodology, or regulatory-context changes trigger a page review. Visible dates identify the latest catalog review, not guaranteed market availability.
Corrections
Source and package issues can be reported through the inquiry form. Corrections are reviewed against the underlying record before publication.

Scope of service

What we do.
What we do not do.

Separating research and coordination from dispensing and medical decision-making is central to how the service is presented and operated.

What US Med Access supports

  • Package and active-ingredient identification
  • Dated EU and US cash-reference comparison
  • Provider credential and availability discussions
  • Route, handling, and documentation questions
  • Case-specific inquiry coordination

What US Med Access does not provide

  • Medical diagnosis or treatment advice
  • Prescription, dispensing, or pharmacy services
  • Guaranteed prices, availability, or delivery dates
  • Universal legal or import-admissibility conclusions
  • Controlled-substance sourcing

Operating principles

Useful information needs
visible boundaries.

These principles shape the catalog, public guidance, and every sourcing conversation.

01

Source transparency

Reference figures are dated, labeled, and linked to a public methodology instead of being presented as live offers.

02

Case-specific review

Package, destination, importer, route, and product requirements are reviewed for the actual request.

03

Role clarity

Consultancy and facilitation are kept distinct from prescribing, dispensing, distribution, and legal advice.

04

Privacy restraint

Inquiry forms request only the information needed to begin a sourcing conversation and should not contain unnecessary health details.

Due diligence

Review the evidence path.

Data & pricingRead the reference methodology Regulatory contextReview process and limitations Data handlingRead the privacy policy

Case-specific review

Have a package-level question?

Share the brand, active ingredient, strength, package, and destination. Do not submit sensitive clinical information through the initial form.

Start an inquiry   ↗